Table 3 Effect of the intervention on maternal, perinatal and neonatal health outcomes
Intervention period (N = 14,814 women) | Control period (N = 11,517 women) | RR (95% CI)a | |||
|---|---|---|---|---|---|
n/N | (%) | n/N | (%) | ||
Maternal secondary outcomes | |||||
Third- or fourth-degree tears | 18/14,814 | (0.12) | 25/11,517 | (0.22) | 0.51 (0.01–29.16) |
Postpartum hemorrhage requiring uterine balloon tamponade or surgical intervention | 28/14,814 | (0.19) | 46/11,517 | (0.40) | 0.38 (0.00–84.07) |
Suspected or confirmed maternal infection requiring therapeutic antibiotics | 114/14,814 | (0.77) | 53/11,517 | (0.46) | 2.12 (0.06–70.96) |
Fetal/neonatal secondary outcomes | |||||
Stillbirth | 449/14,971 | (3.00) | 367/11,624 | (3.16) | 0.97 (0.43–2.19) |
Antepartum stillbirth | 279/14,971 | (1.86) | 286/11,624 | (2.46) | 0.91 (0.34–2.47) |
Intrapartum stillbirth | 163/14,971 | (1.09) | 79/11,624 | (0.68) | 0.90 (0.49–1.65) |
Apgar score <7 at 5 minutes | 670/14,522 | (4.61) | 567/11,257 | (5.04) | 1.17 (0.86–1.59) |
Bag and mask ventilation of newborn | 424/14,522 | (2.92) | 256/11,257 | (2.27) | 1.21 (0.08–18.75) |
Mechanical ventilation of newborn | 293/14,522 | (2.02) | 260/11,257 | (2.31) | 1.29 (0.36–4.66) |
Prolonged (>48 hour) admission in NICU | 1,843/14,522 | (12.7) | 1,014/11,257 | (9.0) | 1.14 (0.47–2.79) |
Newborns requiring NICU admission for hypoxic ischemic encephalopathy | 34/14,522 | (0.23) | 152/11,257 | (1.35) | 0.40 (0.04–3.74) |
Composite neonatal morbidity outcomeb | 376/14,522 | (2.59) | 377/11,257 | (3.35) | 1.11 (0.32–3.79) |
Neonatal death | 200/14,522 | (1.38) | 196/11,257 | (1.74) | 1.31 (0.37–4.71) |
Perinatal death (stillbirth or neonatal death) | 649/14,971 | (4.34) | 563/11,624 | (4.84) | 1.06 (0.41–2.73) |
